SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 17, 17:00
3651.15
-30.3 (-0.82%)
VOLUME 11,843
LIVE
NSE
Apr 17, 17:00
3647.15
-33.15 (-0.9%)
VOLUME 258,444
Management Interviews on Dr Reddys Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Eye significant growth in acquired UCB drugs: Dr Reddy's 

12.01 pm | 10 Apr 2015 |  Source: CNBC-TV18

According to Alok Sonig of DRL, the acquired brands have grown historically at lower double-digits and have a lot of headroom to grow further...

See Rs 400cr increase in top line over next few yrs: Hetero 

3.29 pm | 24 Mar 2015 |  Source: CNBC-TV18

The company has 20 facilities across the globe with portfolio of more than 200 products in 138 countries....

Russia's impact not fully played out in Q3: Dr Reddy's 

5.07 pm | 29 Jan 2015 |  Source: CNBC-TV18

Dr Reddy's Laboratories beat street expectations on both topline and bottomline but operating performance was below estimates. Consolidated net profit...

Likely to file 2 NDAs worth $100 m each soon: Dr Reddy's 

4.51 pm | 29 Oct 2014 |  Source: CNBC-TV18

Discussing the company’s results, GV Prasad co-chairman and CEO, DRL, said the quarter has been a flattish one on the back of high R&D expenses. He ...

1
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.